Global Human Organs-on-Chips Market Growth (Status and Outlook) 2026-2032
The global Human Organs-on-Chips market size is predicted to grow from US$ 219 million in 2025 to US$ 1506 million in 2032; it is expected to grow at a CAGR of 32.4% from 2026 to 2032.
An Human Organs-on-Chip is a multi-channel 3-D microfluidic cell culture chip that simulates the activities, mechanics and physiological response of entire organs and organ systems, a type of artificial organ. It constitutes the subject matter of significant biomedical engineering research, more precisely in bio-MEMS. The convergence of labs-on-chips (LOCs) and cell biology has permitted the study of human physiology in an organ-specific context, introducing a novel model of in vitro multicellular human organisms. One day, they will perhaps abolish the need for animals in drug development and toxin testing. Organ-On-Chip technology not only incorporates multiple cell types but also involves engineering aspects, such as the guided spatial confinement of cells or the incorporation of sensors and microfluidic channels. Usually Human Organs-on-Chip mainly refers to organ chips.
The primary focus of Organ-On-Chip technology is the re-creation of three key aspects of human physiology: the multicellular vascular or epithelial interfaces of organs (for example, blood vessel networks, lung and gut), which function as barriers in tissues; the tissue-level organization of parenchymal cells (for example, liver, heart, skeletal muscle and tumors), which are responsible for the key functional properties of an organ; and the systematic interaction of multiple organs (for example, drug absorption, distribution, metabolism and elimination involving the gut, circulation, liver and kidney).
In addition, the Blood-Brain Barrier is definitely more complex than a simple wall, controlling the passage of most solute that enters or leaves the brain. To address how this molecular sieve affects neural activity, some researchers have simulated the interaction between blood vessels and brain tissue on a series of interconnected "organ chips" when connected through this Blood-Brain Barrier (BBB) ??model. Endothelial cells, pericytes, astrocytes and neurons alter their gene expression. These technologies will achieve even more rapid development and application.The industry's gross profit margin is approximately 40–50%.
Demand for improved drug R&D efficiency drives technology adoption
"Organ-on-a-chip" technology is an in vitro research platform that integrates microfluidics, biomaterials, cell culture, and tissue engineering to simulate the structures, cellular interactions, and dynamic physiological environments of human organs within a miniature device. Traditional 2D cell models struggle to replicate the complex responses of human tissues, while animal experiments face limitations regarding species differences, costs, timelines, and ethical concerns. Pharmaceutical companies need to identify the toxicity, absorption, metabolism, and efficacy of drug candidates at an earlier stage to reduce the risk of clinical trial failure. Organ-on-a-chip systems can simulate blood flow, mechanical stretching, fluid shear stress, and multicellular co-culture environments, providing experimental conditions that more closely mimic the human body for studying organs such as the liver, lungs, intestines, kidneys, and heart, as well as the blood-brain barrier; consequently, they are increasingly being incorporated into drug screening and safety assessment workflows.
Precision medicine and disease modeling expand application boundaries
Biopharmaceutical R&D is shifting from standardized drug development toward targeted therapies, cell therapies, gene therapies, and personalized medicine, placing higher demands on the disease relevance of models and their ability to simulate patient-specific differences. Organ-on-a-chip platforms can utilize patient-derived cells, induced pluripotent stem cells (iPSCs), or tumor tissues to construct specific disease models, enabling the study of disease progression, drug sensitivity, and individual responses to treatment. Multi-organ-on-a-chip systems can also connect various tissue modules to simulate the processes of drug absorption, distribution, metabolism, and toxicity within the human body. As technologies related to cell sources, culture media, sensors, and imaging analysis mature, organ-on-a-chip technology will evolve from simple single-organ functional validation to the study of complex disease mechanisms and the evaluation of combination therapies.
The trend toward replacing animal testing and the establishment of standardization systems are accelerating commercialization.
The global life sciences industry continues to drive efforts to reduce, refine, and replace animal testing, with regulatory bodies, research institutions, and pharmaceutical companies increasingly accepting novel *in vitro* models. If organ-on-a-chip systems can yield stable, reproducible, and verifiable results, they hold the potential for use in specific drug toxicology tests, chemical safety assessments, and medical product research. Meanwhile, advancements in automated culture systems, standardized chip interfaces, real-time sensing, AI-driven image analysis, and high-throughput equipment are lowering operational barriers and enhancing experimental consistency. Future market growth will hinge on cross-laboratory validation, evaluation standards, regulatory approval, and scalable manufacturing capabilities; platforms that are compatible with existing laboratory equipment and feature comprehensive data analysis software and standard operating procedures are the most likely to achieve successful commercialization.
Report Scope
LPI (LP Information)' newest research report, the “Human Organs-on-Chips Industry Forecast” looks at past sales and reviews total world Human Organs-on-Chips sales in 2025, providing a comprehensive analysis by region and market sector of projected Human Organs-on-Chips sales for 2026 through 2032. With Human Organs-on-Chips sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Human Organs-on-Chips industry.
This Insight Report provides a comprehensive analysis of the global Human Organs-on-Chips landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Human Organs-on-Chips portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Human Organs-on-Chips market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Human Organs-on-Chips and breaks down the forecast by Type, by End User, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Human Organs-on-Chips.
This report presents a comprehensive overview, market shares, and growth opportunities of Human Organs-on-Chips market by product type, application, key players and key regions and countries.
An Human Organs-on-Chip is a multi-channel 3-D microfluidic cell culture chip that simulates the activities, mechanics and physiological response of entire organs and organ systems, a type of artificial organ. It constitutes the subject matter of significant biomedical engineering research, more precisely in bio-MEMS. The convergence of labs-on-chips (LOCs) and cell biology has permitted the study of human physiology in an organ-specific context, introducing a novel model of in vitro multicellular human organisms. One day, they will perhaps abolish the need for animals in drug development and toxin testing. Organ-On-Chip technology not only incorporates multiple cell types but also involves engineering aspects, such as the guided spatial confinement of cells or the incorporation of sensors and microfluidic channels. Usually Human Organs-on-Chip mainly refers to organ chips.
The primary focus of Organ-On-Chip technology is the re-creation of three key aspects of human physiology: the multicellular vascular or epithelial interfaces of organs (for example, blood vessel networks, lung and gut), which function as barriers in tissues; the tissue-level organization of parenchymal cells (for example, liver, heart, skeletal muscle and tumors), which are responsible for the key functional properties of an organ; and the systematic interaction of multiple organs (for example, drug absorption, distribution, metabolism and elimination involving the gut, circulation, liver and kidney).
In addition, the Blood-Brain Barrier is definitely more complex than a simple wall, controlling the passage of most solute that enters or leaves the brain. To address how this molecular sieve affects neural activity, some researchers have simulated the interaction between blood vessels and brain tissue on a series of interconnected "organ chips" when connected through this Blood-Brain Barrier (BBB) ??model. Endothelial cells, pericytes, astrocytes and neurons alter their gene expression. These technologies will achieve even more rapid development and application.The industry's gross profit margin is approximately 40–50%.
Key market drivers include the following:
Demand for improved drug R&D efficiency drives technology adoption
"Organ-on-a-chip" technology is an in vitro research platform that integrates microfluidics, biomaterials, cell culture, and tissue engineering to simulate the structures, cellular interactions, and dynamic physiological environments of human organs within a miniature device. Traditional 2D cell models struggle to replicate the complex responses of human tissues, while animal experiments face limitations regarding species differences, costs, timelines, and ethical concerns. Pharmaceutical companies need to identify the toxicity, absorption, metabolism, and efficacy of drug candidates at an earlier stage to reduce the risk of clinical trial failure. Organ-on-a-chip systems can simulate blood flow, mechanical stretching, fluid shear stress, and multicellular co-culture environments, providing experimental conditions that more closely mimic the human body for studying organs such as the liver, lungs, intestines, kidneys, and heart, as well as the blood-brain barrier; consequently, they are increasingly being incorporated into drug screening and safety assessment workflows.
Precision medicine and disease modeling expand application boundaries
Biopharmaceutical R&D is shifting from standardized drug development toward targeted therapies, cell therapies, gene therapies, and personalized medicine, placing higher demands on the disease relevance of models and their ability to simulate patient-specific differences. Organ-on-a-chip platforms can utilize patient-derived cells, induced pluripotent stem cells (iPSCs), or tumor tissues to construct specific disease models, enabling the study of disease progression, drug sensitivity, and individual responses to treatment. Multi-organ-on-a-chip systems can also connect various tissue modules to simulate the processes of drug absorption, distribution, metabolism, and toxicity within the human body. As technologies related to cell sources, culture media, sensors, and imaging analysis mature, organ-on-a-chip technology will evolve from simple single-organ functional validation to the study of complex disease mechanisms and the evaluation of combination therapies.
The trend toward replacing animal testing and the establishment of standardization systems are accelerating commercialization.
The global life sciences industry continues to drive efforts to reduce, refine, and replace animal testing, with regulatory bodies, research institutions, and pharmaceutical companies increasingly accepting novel *in vitro* models. If organ-on-a-chip systems can yield stable, reproducible, and verifiable results, they hold the potential for use in specific drug toxicology tests, chemical safety assessments, and medical product research. Meanwhile, advancements in automated culture systems, standardized chip interfaces, real-time sensing, AI-driven image analysis, and high-throughput equipment are lowering operational barriers and enhancing experimental consistency. Future market growth will hinge on cross-laboratory validation, evaluation standards, regulatory approval, and scalable manufacturing capabilities; platforms that are compatible with existing laboratory equipment and feature comprehensive data analysis software and standard operating procedures are the most likely to achieve successful commercialization.
Report Scope
LPI (LP Information)' newest research report, the “Human Organs-on-Chips Industry Forecast” looks at past sales and reviews total world Human Organs-on-Chips sales in 2025, providing a comprehensive analysis by region and market sector of projected Human Organs-on-Chips sales for 2026 through 2032. With Human Organs-on-Chips sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Human Organs-on-Chips industry.
This Insight Report provides a comprehensive analysis of the global Human Organs-on-Chips landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Human Organs-on-Chips portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Human Organs-on-Chips market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Human Organs-on-Chips and breaks down the forecast by Type, by End User, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Human Organs-on-Chips.
This report presents a comprehensive overview, market shares, and growth opportunities of Human Organs-on-Chips market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Brain-on-a-chip
- Liver-on-a-chip
- Kidney-on-a-chip
- Lung-on-a-chip
- Heart-on-a-chip
- Intestine-on-a-chip
- Vessel-on-a-chip
- Other Organs
Segmentation by Technology:
- Cell Monolayer Chip
- Scaffold or Hydrogel 3D Chip
- Spheroid Chip
- Other
Segmentation by Integration Level:
- Single-Organ Chip
- Multi-Tissue Organ Chip
- Others
Segmentation by End User:
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Cosmetics Industry
- Others
This report also splits the market by region:
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Emulate
- Mimetas
- TissUse
- Valo Health
- CN Bio Innovations
- Hesperos
- Draper Laboratory
- Nortis
- Micronit Microtechnologies B.V.
- Kirkstall
- Cherry Biotech SAS
- Else Kooi Laboratory
- Altis Biosystems
- Bi/ond
- Netri
- Xona Microfluidics
- SynVivo
- Beijing Daxiang Biotech
- AVATARGET
- Suzhou Jiyan Biopharmaceutical
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Human Organs-on-Chips Market Size (2021-2032)
2.1.2 Human Organs-on-Chips Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Human Organs-on-Chips by Country/Region (2021, 2025 & 2032)
2.2 Human Organs-on-Chips Segment by Type
2.2.1 Brain-on-a-chip
2.2.2 Liver-on-a-chip
2.2.3 Kidney-on-a-chip
2.2.4 Lung-on-a-chip
2.2.5 Heart-on-a-chip
2.2.6 Intestine-on-a-chip
2.2.7 Vessel-on-a-chip
2.2.8 Other Organs
2.2.9 Human Organs-on-Chips Market Size by Type
2.2.9.1 Human Organs-on-Chips Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.9.2 Global Human Organs-on-Chips Market Size Market Share by Type (2021-2026)
2.3 Human Organs-on-Chips Segment by Technology
2.3.1 Cell Monolayer Chip
2.3.2 Scaffold or Hydrogel 3D Chip
2.3.3 Spheroid Chip
2.3.4 Other
2.3.5 Human Organs-on-Chips Market Size by Technology
2.3.5.1 Human Organs-on-Chips Market Size CAGR by Technology (2021 VS 2025 VS 2032)
2.3.5.2 Global Human Organs-on-Chips Market Size Market Share by Technology (2021-2026)
2.4 Human Organs-on-Chips Segment by Integration Level
2.4.1 Single-Organ Chip
2.4.2 Multi-Tissue Organ Chip
2.4.3 Others
2.4.4 Human Organs-on-Chips Market Size by Integration Level
2.4.4.1 Human Organs-on-Chips Market Size CAGR by Integration Level (2021 VS 2025 VS 2032)
2.4.4.2 Global Human Organs-on-Chips Market Size Market Share by Integration Level (2021-2026)
2.5 Human Organs-on-Chips Segment by End User
2.5.1 Pharmaceutical & Biotechnology Companies
2.5.2 Academic & Research Institutes
2.5.3 Cosmetics Industry
2.5.4 Others
2.5.5 Human Organs-on-Chips Market Size by End User
2.5.5.1 Human Organs-on-Chips Market Size CAGR by End User (2021 VS 2025 VS 2032)
2.5.5.2 Global Human Organs-on-Chips Market Size Market Share by End User (2021-2026)
3 HUMAN ORGANS-ON-CHIPS MARKET SIZE BY PLAYER
3.1 Human Organs-on-Chips Market Size Market Share by Player
3.1.1 Global Human Organs-on-Chips Revenue by Player (2021-2026)
3.1.2 Global Human Organs-on-Chips Revenue Market Share by Player (2021-2026)
3.2 Global Human Organs-on-Chips Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 HUMAN ORGANS-ON-CHIPS BY REGION
4.1 Human Organs-on-Chips Market Size by Region (2021-2026)
4.2 Global Human Organs-on-Chips Annual Revenue by Country/Region (2021-2026)
4.3 Americas Human Organs-on-Chips Market Size Growth (2021-2026)
4.4 APAC Human Organs-on-Chips Market Size Growth (2021-2026)
4.5 Europe Human Organs-on-Chips Market Size Growth (2021-2026)
4.6 Middle East & Africa Human Organs-on-Chips Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Human Organs-on-Chips Market Size by Country (2021-2026)
5.2 Americas Human Organs-on-Chips Market Size by Type (2021-2026)
5.3 Americas Human Organs-on-Chips Market Size by End User (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Organs-on-Chips Market Size by Region (2021-2026)
6.2 APAC Human Organs-on-Chips Market Size by Type (2021-2026)
6.3 APAC Human Organs-on-Chips Market Size by End User (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Human Organs-on-Chips Market Size by Country (2021-2026)
7.2 Europe Human Organs-on-Chips Market Size by Type (2021-2026)
7.3 Europe Human Organs-on-Chips Market Size by End User (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Human Organs-on-Chips by Region (2021-2026)
8.2 Middle East & Africa Human Organs-on-Chips Market Size by Type (2021-2026)
8.3 Middle East & Africa Human Organs-on-Chips Market Size by End User (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL HUMAN ORGANS-ON-CHIPS MARKET FORECAST
10.1 Global Human Organs-on-Chips Forecast by Region (2027-2032)
10.1.1 Global Human Organs-on-Chips Forecast by Region (2027-2032)
10.1.2 Americas Human Organs-on-Chips Forecast
10.1.3 APAC Human Organs-on-Chips Forecast
10.1.4 Europe Human Organs-on-Chips Forecast
10.1.5 Middle East & Africa Human Organs-on-Chips Forecast
10.2 Americas Human Organs-on-Chips Forecast by Country (2027-2032)
10.2.1 United States Market Human Organs-on-Chips Forecast
10.2.2 Canada Market Human Organs-on-Chips Forecast
10.2.3 Mexico Market Human Organs-on-Chips Forecast
10.2.4 Brazil Market Human Organs-on-Chips Forecast
10.3 APAC Human Organs-on-Chips Forecast by Region (2027-2032)
10.3.1 China Human Organs-on-Chips Market Forecast
10.3.2 Japan Market Human Organs-on-Chips Forecast
10.3.3 Korea Market Human Organs-on-Chips Forecast
10.3.4 Southeast Asia Market Human Organs-on-Chips Forecast
10.3.5 India Market Human Organs-on-Chips Forecast
10.3.6 Australia Market Human Organs-on-Chips Forecast
10.4 Europe Human Organs-on-Chips Forecast by Country (2027-2032)
10.4.1 Germany Market Human Organs-on-Chips Forecast
10.4.2 France Market Human Organs-on-Chips Forecast
10.4.3 UK Market Human Organs-on-Chips Forecast
10.4.4 Italy Market Human Organs-on-Chips Forecast
10.4.5 Russia Market Human Organs-on-Chips Forecast
10.5 Middle East & Africa Human Organs-on-Chips Forecast by Region (2027-2032)
10.5.1 Egypt Market Human Organs-on-Chips Forecast
10.5.2 South Africa Market Human Organs-on-Chips Forecast
10.5.3 Israel Market Human Organs-on-Chips Forecast
10.5.4 Turkey Market Human Organs-on-Chips Forecast
10.6 Global Human Organs-on-Chips Forecast by Type (2027-2032)
10.7 Global Human Organs-on-Chips Forecast by End User (2027-2032)
10.7.1 GCC Countries Market Human Organs-on-Chips Forecast
11 KEY PLAYERS ANALYSIS
11.1 Emulate
11.1.1 Emulate Company Information
11.1.2 Emulate Human Organs-on-Chips Product Offered
11.1.3 Emulate Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Emulate Main Business Overview
11.1.5 Emulate Latest Developments
11.2 Mimetas
11.2.1 Mimetas Company Information
11.2.2 Mimetas Human Organs-on-Chips Product Offered
11.2.3 Mimetas Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Mimetas Main Business Overview
11.2.5 Mimetas Latest Developments
11.3 TissUse
11.3.1 TissUse Company Information
11.3.2 TissUse Human Organs-on-Chips Product Offered
11.3.3 TissUse Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 TissUse Main Business Overview
11.3.5 TissUse Latest Developments
11.4 Valo Health
11.4.1 Valo Health Company Information
11.4.2 Valo Health Human Organs-on-Chips Product Offered
11.4.3 Valo Health Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Valo Health Main Business Overview
11.4.5 Valo Health Latest Developments
11.5 CN Bio Innovations
11.5.1 CN Bio Innovations Company Information
11.5.2 CN Bio Innovations Human Organs-on-Chips Product Offered
11.5.3 CN Bio Innovations Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 CN Bio Innovations Main Business Overview
11.5.5 CN Bio Innovations Latest Developments
11.6 Hesperos
11.6.1 Hesperos Company Information
11.6.2 Hesperos Human Organs-on-Chips Product Offered
11.6.3 Hesperos Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Hesperos Main Business Overview
11.6.5 Hesperos Latest Developments
11.7 Draper Laboratory
11.7.1 Draper Laboratory Company Information
11.7.2 Draper Laboratory Human Organs-on-Chips Product Offered
11.7.3 Draper Laboratory Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Draper Laboratory Main Business Overview
11.7.5 Draper Laboratory Latest Developments
11.8 Nortis
11.8.1 Nortis Company Information
11.8.2 Nortis Human Organs-on-Chips Product Offered
11.8.3 Nortis Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Nortis Main Business Overview
11.8.5 Nortis Latest Developments
11.9 Micronit Microtechnologies B.V.
11.9.1 Micronit Microtechnologies B.V. Company Information
11.9.2 Micronit Microtechnologies B.V. Human Organs-on-Chips Product Offered
11.9.3 Micronit Microtechnologies B.V. Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Micronit Microtechnologies B.V. Main Business Overview
11.9.5 Micronit Microtechnologies B.V. Latest Developments
11.10 Kirkstall
11.10.1 Kirkstall Company Information
11.10.2 Kirkstall Human Organs-on-Chips Product Offered
11.10.3 Kirkstall Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Kirkstall Main Business Overview
11.10.5 Kirkstall Latest Developments
11.11 Cherry Biotech SAS
11.11.1 Cherry Biotech SAS Company Information
11.11.2 Cherry Biotech SAS Human Organs-on-Chips Product Offered
11.11.3 Cherry Biotech SAS Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Cherry Biotech SAS Main Business Overview
11.11.5 Cherry Biotech SAS Latest Developments
11.12 Else Kooi Laboratory
11.12.1 Else Kooi Laboratory Company Information
11.12.2 Else Kooi Laboratory Human Organs-on-Chips Product Offered
11.12.3 Else Kooi Laboratory Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Else Kooi Laboratory Main Business Overview
11.12.5 Else Kooi Laboratory Latest Developments
11.13 Altis Biosystems
11.13.1 Altis Biosystems Company Information
11.13.2 Altis Biosystems Human Organs-on-Chips Product Offered
11.13.3 Altis Biosystems Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Altis Biosystems Main Business Overview
11.13.5 Altis Biosystems Latest Developments
11.14 Bi/ond
11.14.1 Bi/ond Company Information
11.14.2 Bi/ond Human Organs-on-Chips Product Offered
11.14.3 Bi/ond Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Bi/ond Main Business Overview
11.14.5 Bi/ond Latest Developments
11.15 Netri
11.15.1 Netri Company Information
11.15.2 Netri Human Organs-on-Chips Product Offered
11.15.3 Netri Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Netri Main Business Overview
11.15.5 Netri Latest Developments
11.16 Xona Microfluidics
11.16.1 Xona Microfluidics Company Information
11.16.2 Xona Microfluidics Human Organs-on-Chips Product Offered
11.16.3 Xona Microfluidics Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Xona Microfluidics Main Business Overview
11.16.5 Xona Microfluidics Latest Developments
11.17 SynVivo
11.17.1 SynVivo Company Information
11.17.2 SynVivo Human Organs-on-Chips Product Offered
11.17.3 SynVivo Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 SynVivo Main Business Overview
11.17.5 SynVivo Latest Developments
11.18 Beijing Daxiang Biotech
11.18.1 Beijing Daxiang Biotech Company Information
11.18.2 Beijing Daxiang Biotech Human Organs-on-Chips Product Offered
11.18.3 Beijing Daxiang Biotech Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Beijing Daxiang Biotech Main Business Overview
11.18.5 Beijing Daxiang Biotech Latest Developments
11.19 AVATARGET
11.19.1 AVATARGET Company Information
11.19.2 AVATARGET Human Organs-on-Chips Product Offered
11.19.3 AVATARGET Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 AVATARGET Main Business Overview
11.19.5 AVATARGET Latest Developments
11.20 Suzhou Jiyan Biopharmaceutical
11.20.1 Suzhou Jiyan Biopharmaceutical Company Information
11.20.2 Suzhou Jiyan Biopharmaceutical Human Organs-on-Chips Product Offered
11.20.3 Suzhou Jiyan Biopharmaceutical Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 Suzhou Jiyan Biopharmaceutical Main Business Overview
11.20.5 Suzhou Jiyan Biopharmaceutical Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Human Organs-on-Chips Market Size (2021-2032)
2.1.2 Human Organs-on-Chips Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Human Organs-on-Chips by Country/Region (2021, 2025 & 2032)
2.2 Human Organs-on-Chips Segment by Type
2.2.1 Brain-on-a-chip
2.2.2 Liver-on-a-chip
2.2.3 Kidney-on-a-chip
2.2.4 Lung-on-a-chip
2.2.5 Heart-on-a-chip
2.2.6 Intestine-on-a-chip
2.2.7 Vessel-on-a-chip
2.2.8 Other Organs
2.2.9 Human Organs-on-Chips Market Size by Type
2.2.9.1 Human Organs-on-Chips Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.9.2 Global Human Organs-on-Chips Market Size Market Share by Type (2021-2026)
2.3 Human Organs-on-Chips Segment by Technology
2.3.1 Cell Monolayer Chip
2.3.2 Scaffold or Hydrogel 3D Chip
2.3.3 Spheroid Chip
2.3.4 Other
2.3.5 Human Organs-on-Chips Market Size by Technology
2.3.5.1 Human Organs-on-Chips Market Size CAGR by Technology (2021 VS 2025 VS 2032)
2.3.5.2 Global Human Organs-on-Chips Market Size Market Share by Technology (2021-2026)
2.4 Human Organs-on-Chips Segment by Integration Level
2.4.1 Single-Organ Chip
2.4.2 Multi-Tissue Organ Chip
2.4.3 Others
2.4.4 Human Organs-on-Chips Market Size by Integration Level
2.4.4.1 Human Organs-on-Chips Market Size CAGR by Integration Level (2021 VS 2025 VS 2032)
2.4.4.2 Global Human Organs-on-Chips Market Size Market Share by Integration Level (2021-2026)
2.5 Human Organs-on-Chips Segment by End User
2.5.1 Pharmaceutical & Biotechnology Companies
2.5.2 Academic & Research Institutes
2.5.3 Cosmetics Industry
2.5.4 Others
2.5.5 Human Organs-on-Chips Market Size by End User
2.5.5.1 Human Organs-on-Chips Market Size CAGR by End User (2021 VS 2025 VS 2032)
2.5.5.2 Global Human Organs-on-Chips Market Size Market Share by End User (2021-2026)
3 HUMAN ORGANS-ON-CHIPS MARKET SIZE BY PLAYER
3.1 Human Organs-on-Chips Market Size Market Share by Player
3.1.1 Global Human Organs-on-Chips Revenue by Player (2021-2026)
3.1.2 Global Human Organs-on-Chips Revenue Market Share by Player (2021-2026)
3.2 Global Human Organs-on-Chips Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 HUMAN ORGANS-ON-CHIPS BY REGION
4.1 Human Organs-on-Chips Market Size by Region (2021-2026)
4.2 Global Human Organs-on-Chips Annual Revenue by Country/Region (2021-2026)
4.3 Americas Human Organs-on-Chips Market Size Growth (2021-2026)
4.4 APAC Human Organs-on-Chips Market Size Growth (2021-2026)
4.5 Europe Human Organs-on-Chips Market Size Growth (2021-2026)
4.6 Middle East & Africa Human Organs-on-Chips Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Human Organs-on-Chips Market Size by Country (2021-2026)
5.2 Americas Human Organs-on-Chips Market Size by Type (2021-2026)
5.3 Americas Human Organs-on-Chips Market Size by End User (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Organs-on-Chips Market Size by Region (2021-2026)
6.2 APAC Human Organs-on-Chips Market Size by Type (2021-2026)
6.3 APAC Human Organs-on-Chips Market Size by End User (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Human Organs-on-Chips Market Size by Country (2021-2026)
7.2 Europe Human Organs-on-Chips Market Size by Type (2021-2026)
7.3 Europe Human Organs-on-Chips Market Size by End User (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Human Organs-on-Chips by Region (2021-2026)
8.2 Middle East & Africa Human Organs-on-Chips Market Size by Type (2021-2026)
8.3 Middle East & Africa Human Organs-on-Chips Market Size by End User (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL HUMAN ORGANS-ON-CHIPS MARKET FORECAST
10.1 Global Human Organs-on-Chips Forecast by Region (2027-2032)
10.1.1 Global Human Organs-on-Chips Forecast by Region (2027-2032)
10.1.2 Americas Human Organs-on-Chips Forecast
10.1.3 APAC Human Organs-on-Chips Forecast
10.1.4 Europe Human Organs-on-Chips Forecast
10.1.5 Middle East & Africa Human Organs-on-Chips Forecast
10.2 Americas Human Organs-on-Chips Forecast by Country (2027-2032)
10.2.1 United States Market Human Organs-on-Chips Forecast
10.2.2 Canada Market Human Organs-on-Chips Forecast
10.2.3 Mexico Market Human Organs-on-Chips Forecast
10.2.4 Brazil Market Human Organs-on-Chips Forecast
10.3 APAC Human Organs-on-Chips Forecast by Region (2027-2032)
10.3.1 China Human Organs-on-Chips Market Forecast
10.3.2 Japan Market Human Organs-on-Chips Forecast
10.3.3 Korea Market Human Organs-on-Chips Forecast
10.3.4 Southeast Asia Market Human Organs-on-Chips Forecast
10.3.5 India Market Human Organs-on-Chips Forecast
10.3.6 Australia Market Human Organs-on-Chips Forecast
10.4 Europe Human Organs-on-Chips Forecast by Country (2027-2032)
10.4.1 Germany Market Human Organs-on-Chips Forecast
10.4.2 France Market Human Organs-on-Chips Forecast
10.4.3 UK Market Human Organs-on-Chips Forecast
10.4.4 Italy Market Human Organs-on-Chips Forecast
10.4.5 Russia Market Human Organs-on-Chips Forecast
10.5 Middle East & Africa Human Organs-on-Chips Forecast by Region (2027-2032)
10.5.1 Egypt Market Human Organs-on-Chips Forecast
10.5.2 South Africa Market Human Organs-on-Chips Forecast
10.5.3 Israel Market Human Organs-on-Chips Forecast
10.5.4 Turkey Market Human Organs-on-Chips Forecast
10.6 Global Human Organs-on-Chips Forecast by Type (2027-2032)
10.7 Global Human Organs-on-Chips Forecast by End User (2027-2032)
10.7.1 GCC Countries Market Human Organs-on-Chips Forecast
11 KEY PLAYERS ANALYSIS
11.1 Emulate
11.1.1 Emulate Company Information
11.1.2 Emulate Human Organs-on-Chips Product Offered
11.1.3 Emulate Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Emulate Main Business Overview
11.1.5 Emulate Latest Developments
11.2 Mimetas
11.2.1 Mimetas Company Information
11.2.2 Mimetas Human Organs-on-Chips Product Offered
11.2.3 Mimetas Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Mimetas Main Business Overview
11.2.5 Mimetas Latest Developments
11.3 TissUse
11.3.1 TissUse Company Information
11.3.2 TissUse Human Organs-on-Chips Product Offered
11.3.3 TissUse Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 TissUse Main Business Overview
11.3.5 TissUse Latest Developments
11.4 Valo Health
11.4.1 Valo Health Company Information
11.4.2 Valo Health Human Organs-on-Chips Product Offered
11.4.3 Valo Health Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Valo Health Main Business Overview
11.4.5 Valo Health Latest Developments
11.5 CN Bio Innovations
11.5.1 CN Bio Innovations Company Information
11.5.2 CN Bio Innovations Human Organs-on-Chips Product Offered
11.5.3 CN Bio Innovations Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 CN Bio Innovations Main Business Overview
11.5.5 CN Bio Innovations Latest Developments
11.6 Hesperos
11.6.1 Hesperos Company Information
11.6.2 Hesperos Human Organs-on-Chips Product Offered
11.6.3 Hesperos Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Hesperos Main Business Overview
11.6.5 Hesperos Latest Developments
11.7 Draper Laboratory
11.7.1 Draper Laboratory Company Information
11.7.2 Draper Laboratory Human Organs-on-Chips Product Offered
11.7.3 Draper Laboratory Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Draper Laboratory Main Business Overview
11.7.5 Draper Laboratory Latest Developments
11.8 Nortis
11.8.1 Nortis Company Information
11.8.2 Nortis Human Organs-on-Chips Product Offered
11.8.3 Nortis Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Nortis Main Business Overview
11.8.5 Nortis Latest Developments
11.9 Micronit Microtechnologies B.V.
11.9.1 Micronit Microtechnologies B.V. Company Information
11.9.2 Micronit Microtechnologies B.V. Human Organs-on-Chips Product Offered
11.9.3 Micronit Microtechnologies B.V. Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Micronit Microtechnologies B.V. Main Business Overview
11.9.5 Micronit Microtechnologies B.V. Latest Developments
11.10 Kirkstall
11.10.1 Kirkstall Company Information
11.10.2 Kirkstall Human Organs-on-Chips Product Offered
11.10.3 Kirkstall Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Kirkstall Main Business Overview
11.10.5 Kirkstall Latest Developments
11.11 Cherry Biotech SAS
11.11.1 Cherry Biotech SAS Company Information
11.11.2 Cherry Biotech SAS Human Organs-on-Chips Product Offered
11.11.3 Cherry Biotech SAS Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Cherry Biotech SAS Main Business Overview
11.11.5 Cherry Biotech SAS Latest Developments
11.12 Else Kooi Laboratory
11.12.1 Else Kooi Laboratory Company Information
11.12.2 Else Kooi Laboratory Human Organs-on-Chips Product Offered
11.12.3 Else Kooi Laboratory Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Else Kooi Laboratory Main Business Overview
11.12.5 Else Kooi Laboratory Latest Developments
11.13 Altis Biosystems
11.13.1 Altis Biosystems Company Information
11.13.2 Altis Biosystems Human Organs-on-Chips Product Offered
11.13.3 Altis Biosystems Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Altis Biosystems Main Business Overview
11.13.5 Altis Biosystems Latest Developments
11.14 Bi/ond
11.14.1 Bi/ond Company Information
11.14.2 Bi/ond Human Organs-on-Chips Product Offered
11.14.3 Bi/ond Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Bi/ond Main Business Overview
11.14.5 Bi/ond Latest Developments
11.15 Netri
11.15.1 Netri Company Information
11.15.2 Netri Human Organs-on-Chips Product Offered
11.15.3 Netri Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Netri Main Business Overview
11.15.5 Netri Latest Developments
11.16 Xona Microfluidics
11.16.1 Xona Microfluidics Company Information
11.16.2 Xona Microfluidics Human Organs-on-Chips Product Offered
11.16.3 Xona Microfluidics Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Xona Microfluidics Main Business Overview
11.16.5 Xona Microfluidics Latest Developments
11.17 SynVivo
11.17.1 SynVivo Company Information
11.17.2 SynVivo Human Organs-on-Chips Product Offered
11.17.3 SynVivo Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 SynVivo Main Business Overview
11.17.5 SynVivo Latest Developments
11.18 Beijing Daxiang Biotech
11.18.1 Beijing Daxiang Biotech Company Information
11.18.2 Beijing Daxiang Biotech Human Organs-on-Chips Product Offered
11.18.3 Beijing Daxiang Biotech Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Beijing Daxiang Biotech Main Business Overview
11.18.5 Beijing Daxiang Biotech Latest Developments
11.19 AVATARGET
11.19.1 AVATARGET Company Information
11.19.2 AVATARGET Human Organs-on-Chips Product Offered
11.19.3 AVATARGET Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 AVATARGET Main Business Overview
11.19.5 AVATARGET Latest Developments
11.20 Suzhou Jiyan Biopharmaceutical
11.20.1 Suzhou Jiyan Biopharmaceutical Company Information
11.20.2 Suzhou Jiyan Biopharmaceutical Human Organs-on-Chips Product Offered
11.20.3 Suzhou Jiyan Biopharmaceutical Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 Suzhou Jiyan Biopharmaceutical Main Business Overview
11.20.5 Suzhou Jiyan Biopharmaceutical Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Human Organs-on-Chips Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Human Organs-on-Chips Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Brain-on-a-chip
Table 4. Major Players of Liver-on-a-chip
Table 5. Major Players of Kidney-on-a-chip
Table 6. Major Players of Lung-on-a-chip
Table 7. Major Players of Heart-on-a-chip
Table 8. Major Players of Intestine-on-a-chip
Table 9. Major Players of Vessel-on-a-chip
Table 10. Major Players of Other Organs
Table 11. Human Organs-on-Chips Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 12. Global Human Organs-on-Chips Market Size by Type (2021-2026) & ($ millions)
Table 13. Global Human Organs-on-Chips Market Size Market Share by Type (2021-2026)
Table 14. Major Players of Cell Monolayer Chip
Table 15. Major Players of Scaffold or Hydrogel 3D Chip
Table 16. Major Players of Spheroid Chip
Table 17. Major Players of Other
Table 18. Human Organs-on-Chips Market Size CAGR by Technology (2021 VS 2025 VS 2032) & ($ millions)
Table 19. Global Human Organs-on-Chips Market Size by Technology (2021-2026) & ($ millions)
Table 20. Global Human Organs-on-Chips Market Size Market Share by Technology (2021-2026)
Table 21. Major Players of Single-Organ Chip
Table 22. Major Players of Multi-Tissue Organ Chip
Table 23. Major Players of Others
Table 24. Human Organs-on-Chips Market Size CAGR by Integration Level (2021 VS 2025 VS 2032) & ($ millions)
Table 25. Global Human Organs-on-Chips Market Size by Integration Level (2021-2026) & ($ millions)
Table 26. Global Human Organs-on-Chips Market Size Market Share by Integration Level (2021-2026)
Table 27. Human Organs-on-Chips Market Size CAGR by End User (2021 VS 2025 VS 2032) & ($ millions)
Table 28. Global Human Organs-on-Chips Market Size by End User (2021-2026) & ($ millions)
Table 29. Global Human Organs-on-Chips Market Size Market Share by End User (2021-2026)
Table 30. Global Human Organs-on-Chips Revenue by Player (2021-2026) & ($ millions)
Table 31. Global Human Organs-on-Chips Revenue Market Share by Player (2021-2026)
Table 32. Human Organs-on-Chips Key Players Head office and Products Offered
Table 33. Human Organs-on-Chips Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 34. New Products and Potential Entrants
Table 35. Mergers & Acquisitions, Expansion
Table 36. Global Human Organs-on-Chips Market Size by Region (2021-2026) & ($ millions)
Table 37. Global Human Organs-on-Chips Market Size Market Share by Region (2021-2026)
Table 38. Global Human Organs-on-Chips Revenue by Country/Region (2021-2026) & ($ millions)
Table 39. Global Human Organs-on-Chips Revenue Market Share by Country/Region (2021-2026)
Table 40. Americas Human Organs-on-Chips Market Size by Country (2021-2026) & ($ millions)
Table 41. Americas Human Organs-on-Chips Market Size Market Share by Country (2021-2026)
Table 42. Americas Human Organs-on-Chips Market Size by Type (2021-2026) & ($ millions)
Table 43. Americas Human Organs-on-Chips Market Size Market Share by Type (2021-2026)
Table 44. Americas Human Organs-on-Chips Market Size by End User (2021-2026) & ($ millions)
Table 45. Americas Human Organs-on-Chips Market Size Market Share by End User (2021-2026)
Table 46. APAC Human Organs-on-Chips Market Size by Region (2021-2026) & ($ millions)
Table 47. APAC Human Organs-on-Chips Market Size Market Share by Region (2021-2026)
Table 48. APAC Human Organs-on-Chips Market Size by Type (2021-2026) & ($ millions)
Table 49. APAC Human Organs-on-Chips Market Size by End User (2021-2026) & ($ millions)
Table 50. Europe Human Organs-on-Chips Market Size by Country (2021-2026) & ($ millions)
Table 51. Europe Human Organs-on-Chips Market Size Market Share by Country (2021-2026)
Table 52. Europe Human Organs-on-Chips Market Size by Type (2021-2026) & ($ millions)
Table 53. Europe Human Organs-on-Chips Market Size by End User (2021-2026) & ($ millions)
Table 54. Middle East & Africa Human Organs-on-Chips Market Size by Region (2021-2026) & ($ millions)
Table 55. Middle East & Africa Human Organs-on-Chips Market Size by Type (2021-2026) & ($ millions)
Table 56. Middle East & Africa Human Organs-on-Chips Market Size by End User (2021-2026) & ($ millions)
Table 57. Key Market Drivers & Growth Opportunities of Human Organs-on-Chips
Table 58. Key Market Challenges & Risks of Human Organs-on-Chips
Table 59. Key Industry Trends of Human Organs-on-Chips
Table 60. Global Human Organs-on-Chips Market Size Forecast by Region (2027-2032) & ($ millions)
Table 61. Global Human Organs-on-Chips Market Size Market Share Forecast by Region (2027-2032)
Table 62. Global Human Organs-on-Chips Market Size Forecast by Type (2027-2032) & ($ millions)
Table 63. Global Human Organs-on-Chips Market Size Forecast by End User (2027-2032) & ($ millions)
Table 64. Emulate Details, Company Type, Human Organs-on-Chips Area Served and Its Competitors
Table 65. Emulate Human Organs-on-Chips Product Offered
Table 66. Emulate Human Organs-on-Chips Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 67. Emulate Main Business
Table 68. Emulate Latest Developments
Table 69. Mimetas Details, Company Type, Human Organs-on-Chips Area Served and Its Competitors
Table 70. Mimetas Human Organs-on-Chips Product Offered
Table 71. Mimetas Human Organs-on-Chips Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 72. Mimetas Main Business
Table 73. Mimetas Latest Developments
Table 74. TissUse Details, Company Type, Human Organs-on-Chips Area Served and Its Competitors
Table 75. TissUse Human Organs-on-Chips Product Offered
Table 76. TissUse Human Organs-on-Chips Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 77. TissUse Main Business
Table 78. TissUse Latest Developments
Table 79. Valo Health Details, Company Type, Human Organs-on-Chips Area Served and Its Competitors
Table 80. Valo Health Human Organs-on-Chips Product Offered
Table 81. Valo Health Human Organs-on-Chips Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 82. Valo Health Main Business
Table 83. Valo Health Latest Developments
Table 84. CN Bio Innovations Details, Company Type, Human Organs-on-Chips Area Served and Its Competitors
Table 85. CN Bio Innovations Human Organs-on-Chips Product Offered
Table 86. CN Bio Innovations Human Organs-on-Chips Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 87. CN Bio Innovations Main Business
Table 88. CN Bio Innovations Latest Developments
Table 89. Hesperos Details, Company Type, Human Organs-on-Chips Area Served and Its Competitors
Table 90. Hesperos Human Organs-on-Chips Product Offered
Table 91. Hesperos Human Organs-on-Chips Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 92. Hesperos Main Business
Table 93. Hesperos Latest Developments
Table 94. Draper Laboratory Details, Company Type, Human Organs-on-Chips Area Served and Its Competitors
Table 95. Draper Laboratory Human Organs-on-Chips Product Offered
Table 96. Draper Laboratory Human Organs-on-Chips Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 97. Draper Laboratory Main Business
Table 98. Draper Laboratory Latest Developments
Table 99. Nortis Details, Company Type, Human Organs-on-Chips Area Served and Its Competitors
Table 100. Nortis Human Organs-on-Chips Product Offered
Table 101. Nortis Human Organs-on-Chips Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 102. Nortis Main Business
Table 103. Nortis Latest Developments
Table 104. Micronit Microtechnologies B.V. Details, Company Type, Human Organs-on-Chips Area Served and Its Competitors
Table 105. Micronit Microtechnologies B.V. Human Organs-on-Chips Product Offered
Table 106. Micronit Microtechnologies B.V. Human Organs-on-Chips Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 107. Micronit Microtechnologies B.V. Main Business
Table 108. Micronit Microtechnologies B.V. Latest Developments
Table 109. Kirkstall Details, Company Type, Human Organs-on-Chips Area Served and Its Competitors
Table 110. Kirkstall Human Organs-on-Chips Product Offered
Table 111. Kirkstall Human Organs-on-Chips Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 112. Kirkstall Main Business
Table 113. Kirkstall Latest Developments
Table 114. Cherry Biotech SAS Details, Company Type, Human Organs-on-Chips Area Served and Its Competitors
Table 115. Cherry Biotech SAS Human Organs-on-Chips Product Offered
Table 116. Cherry Biotech SAS Human Organs-on-Chips Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 117. Cherry Biotech SAS Main Business
Table 118. Cherry Biotech SAS Latest Developments
Table 119. Else Kooi Laboratory Details, Company Type, Human Organs-on-Chips Area Served and Its Competitors
Table 120. Else Kooi Laboratory Human Organs-on-Chips Product Offered
Table 121. Else Kooi Laboratory Human Organs-on-Chips Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 122. Else Kooi Laboratory Main Business
Table 123. Else Kooi Laboratory Latest Developments
Table 124. Altis Biosystems Details, Company Type, Human Organs-on-Chips Area Served and Its Competitors
Table 125. Altis Biosystems Human Organs-on-Chips Product Offered
Table 126. Altis Biosystems Human Organs-on-Chips Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 127. Altis Biosystems Main Business
Table 128. Altis Biosystems Latest Developments
Table 129. Bi/ond Details, Company Type, Human Organs-on-Chips Area Served and Its Competitors
Table 130. Bi/ond Human Organs-on-Chips Product Offered
Table 131. Bi/ond Human Organs-on-Chips Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 132. Bi/ond Main Business
Table 133. Bi/ond Latest Developments
Table 134. Netri Details, Company Type, Human Organs-on-Chips Area Served and Its Competitors
Table 135. Netri Human Organs-on-Chips Product Offered
Table 136. Netri Human Organs-on-Chips Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 137. Netri Main Business
Table 138. Netri Latest Developments
Table 139. Xona Microfluidics Details, Company Type, Human Organs-on-Chips Area Served and Its Competitors
Table 140. Xona Microfluidics Human Organs-on-Chips Product Offered
Table 141. Xona Microfluidics Human Organs-on-Chips Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 142. Xona Microfluidics Main Business
Table 143. Xona Microfluidics Latest Developments
Table 144. SynVivo Details, Company Type, Human Organs-on-Chips Area Served and Its Competitors
Table 145. SynVivo Human Organs-on-Chips Product Offered
Table 146. SynVivo Human Organs-on-Chips Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 147. SynVivo Main Business
Table 148. SynVivo Latest Developments
Table 149. Beijing Daxiang Biotech Details, Company Type, Human Organs-on-Chips Area Served and Its Competitors
Table 150. Beijing Daxiang Biotech Human Organs-on-Chips Product Offered
Table 151. Beijing Daxiang Biotech Human Organs-on-Chips Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 152. Beijing Daxiang Biotech Main Business
Table 153. Beijing Daxiang Biotech Latest Developments
Table 154. AVATARGET Details, Company Type, Human Organs-on-Chips Area Served and Its Competitors
Table 155. AVATARGET Human Organs-on-Chips Product Offered
Table 156. AVATARGET Human Organs-on-Chips Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 157. AVATARGET Main Business
Table 158. AVATARGET Latest Developments
Table 159. Suzhou Jiyan Biopharmaceutical Details, Company Type, Human Organs-on-Chips Area Served and Its Competitors
Table 160. Suzhou Jiyan Biopharmaceutical Human Organs-on-Chips Product Offered
Table 161. Suzhou Jiyan Biopharmaceutical Human Organs-on-Chips Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 162. Suzhou Jiyan Biopharmaceutical Main Business
Table 163. Suzhou Jiyan Biopharmaceutical Latest Developments
Table 1. Human Organs-on-Chips Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Human Organs-on-Chips Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Brain-on-a-chip
Table 4. Major Players of Liver-on-a-chip
Table 5. Major Players of Kidney-on-a-chip
Table 6. Major Players of Lung-on-a-chip
Table 7. Major Players of Heart-on-a-chip
Table 8. Major Players of Intestine-on-a-chip
Table 9. Major Players of Vessel-on-a-chip
Table 10. Major Players of Other Organs
Table 11. Human Organs-on-Chips Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 12. Global Human Organs-on-Chips Market Size by Type (2021-2026) & ($ millions)
Table 13. Global Human Organs-on-Chips Market Size Market Share by Type (2021-2026)
Table 14. Major Players of Cell Monolayer Chip
Table 15. Major Players of Scaffold or Hydrogel 3D Chip
Table 16. Major Players of Spheroid Chip
Table 17. Major Players of Other
Table 18. Human Organs-on-Chips Market Size CAGR by Technology (2021 VS 2025 VS 2032) & ($ millions)
Table 19. Global Human Organs-on-Chips Market Size by Technology (2021-2026) & ($ millions)
Table 20. Global Human Organs-on-Chips Market Size Market Share by Technology (2021-2026)
Table 21. Major Players of Single-Organ Chip
Table 22. Major Players of Multi-Tissue Organ Chip
Table 23. Major Players of Others
Table 24. Human Organs-on-Chips Market Size CAGR by Integration Level (2021 VS 2025 VS 2032) & ($ millions)
Table 25. Global Human Organs-on-Chips Market Size by Integration Level (2021-2026) & ($ millions)
Table 26. Global Human Organs-on-Chips Market Size Market Share by Integration Level (2021-2026)
Table 27. Human Organs-on-Chips Market Size CAGR by End User (2021 VS 2025 VS 2032) & ($ millions)
Table 28. Global Human Organs-on-Chips Market Size by End User (2021-2026) & ($ millions)
Table 29. Global Human Organs-on-Chips Market Size Market Share by End User (2021-2026)
Table 30. Global Human Organs-on-Chips Revenue by Player (2021-2026) & ($ millions)
Table 31. Global Human Organs-on-Chips Revenue Market Share by Player (2021-2026)
Table 32. Human Organs-on-Chips Key Players Head office and Products Offered
Table 33. Human Organs-on-Chips Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 34. New Products and Potential Entrants
Table 35. Mergers & Acquisitions, Expansion
Table 36. Global Human Organs-on-Chips Market Size by Region (2021-2026) & ($ millions)
Table 37. Global Human Organs-on-Chips Market Size Market Share by Region (2021-2026)
Table 38. Global Human Organs-on-Chips Revenue by Country/Region (2021-2026) & ($ millions)
Table 39. Global Human Organs-on-Chips Revenue Market Share by Country/Region (2021-2026)
Table 40. Americas Human Organs-on-Chips Market Size by Country (2021-2026) & ($ millions)
Table 41. Americas Human Organs-on-Chips Market Size Market Share by Country (2021-2026)
Table 42. Americas Human Organs-on-Chips Market Size by Type (2021-2026) & ($ millions)
Table 43. Americas Human Organs-on-Chips Market Size Market Share by Type (2021-2026)
Table 44. Americas Human Organs-on-Chips Market Size by End User (2021-2026) & ($ millions)
Table 45. Americas Human Organs-on-Chips Market Size Market Share by End User (2021-2026)
Table 46. APAC Human Organs-on-Chips Market Size by Region (2021-2026) & ($ millions)
Table 47. APAC Human Organs-on-Chips Market Size Market Share by Region (2021-2026)
Table 48. APAC Human Organs-on-Chips Market Size by Type (2021-2026) & ($ millions)
Table 49. APAC Human Organs-on-Chips Market Size by End User (2021-2026) & ($ millions)
Table 50. Europe Human Organs-on-Chips Market Size by Country (2021-2026) & ($ millions)
Table 51. Europe Human Organs-on-Chips Market Size Market Share by Country (2021-2026)
Table 52. Europe Human Organs-on-Chips Market Size by Type (2021-2026) & ($ millions)
Table 53. Europe Human Organs-on-Chips Market Size by End User (2021-2026) & ($ millions)
Table 54. Middle East & Africa Human Organs-on-Chips Market Size by Region (2021-2026) & ($ millions)
Table 55. Middle East & Africa Human Organs-on-Chips Market Size by Type (2021-2026) & ($ millions)
Table 56. Middle East & Africa Human Organs-on-Chips Market Size by End User (2021-2026) & ($ millions)
Table 57. Key Market Drivers & Growth Opportunities of Human Organs-on-Chips
Table 58. Key Market Challenges & Risks of Human Organs-on-Chips
Table 59. Key Industry Trends of Human Organs-on-Chips
Table 60. Global Human Organs-on-Chips Market Size Forecast by Region (2027-2032) & ($ millions)
Table 61. Global Human Organs-on-Chips Market Size Market Share Forecast by Region (2027-2032)
Table 62. Global Human Organs-on-Chips Market Size Forecast by Type (2027-2032) & ($ millions)
Table 63. Global Human Organs-on-Chips Market Size Forecast by End User (2027-2032) & ($ millions)
Table 64. Emulate Details, Company Type, Human Organs-on-Chips Area Served and Its Competitors
Table 65. Emulate Human Organs-on-Chips Product Offered
Table 66. Emulate Human Organs-on-Chips Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 67. Emulate Main Business
Table 68. Emulate Latest Developments
Table 69. Mimetas Details, Company Type, Human Organs-on-Chips Area Served and Its Competitors
Table 70. Mimetas Human Organs-on-Chips Product Offered
Table 71. Mimetas Human Organs-on-Chips Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 72. Mimetas Main Business
Table 73. Mimetas Latest Developments
Table 74. TissUse Details, Company Type, Human Organs-on-Chips Area Served and Its Competitors
Table 75. TissUse Human Organs-on-Chips Product Offered
Table 76. TissUse Human Organs-on-Chips Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 77. TissUse Main Business
Table 78. TissUse Latest Developments
Table 79. Valo Health Details, Company Type, Human Organs-on-Chips Area Served and Its Competitors
Table 80. Valo Health Human Organs-on-Chips Product Offered
Table 81. Valo Health Human Organs-on-Chips Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 82. Valo Health Main Business
Table 83. Valo Health Latest Developments
Table 84. CN Bio Innovations Details, Company Type, Human Organs-on-Chips Area Served and Its Competitors
Table 85. CN Bio Innovations Human Organs-on-Chips Product Offered
Table 86. CN Bio Innovations Human Organs-on-Chips Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 87. CN Bio Innovations Main Business
Table 88. CN Bio Innovations Latest Developments
Table 89. Hesperos Details, Company Type, Human Organs-on-Chips Area Served and Its Competitors
Table 90. Hesperos Human Organs-on-Chips Product Offered
Table 91. Hesperos Human Organs-on-Chips Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 92. Hesperos Main Business
Table 93. Hesperos Latest Developments
Table 94. Draper Laboratory Details, Company Type, Human Organs-on-Chips Area Served and Its Competitors
Table 95. Draper Laboratory Human Organs-on-Chips Product Offered
Table 96. Draper Laboratory Human Organs-on-Chips Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 97. Draper Laboratory Main Business
Table 98. Draper Laboratory Latest Developments
Table 99. Nortis Details, Company Type, Human Organs-on-Chips Area Served and Its Competitors
Table 100. Nortis Human Organs-on-Chips Product Offered
Table 101. Nortis Human Organs-on-Chips Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 102. Nortis Main Business
Table 103. Nortis Latest Developments
Table 104. Micronit Microtechnologies B.V. Details, Company Type, Human Organs-on-Chips Area Served and Its Competitors
Table 105. Micronit Microtechnologies B.V. Human Organs-on-Chips Product Offered
Table 106. Micronit Microtechnologies B.V. Human Organs-on-Chips Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 107. Micronit Microtechnologies B.V. Main Business
Table 108. Micronit Microtechnologies B.V. Latest Developments
Table 109. Kirkstall Details, Company Type, Human Organs-on-Chips Area Served and Its Competitors
Table 110. Kirkstall Human Organs-on-Chips Product Offered
Table 111. Kirkstall Human Organs-on-Chips Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 112. Kirkstall Main Business
Table 113. Kirkstall Latest Developments
Table 114. Cherry Biotech SAS Details, Company Type, Human Organs-on-Chips Area Served and Its Competitors
Table 115. Cherry Biotech SAS Human Organs-on-Chips Product Offered
Table 116. Cherry Biotech SAS Human Organs-on-Chips Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 117. Cherry Biotech SAS Main Business
Table 118. Cherry Biotech SAS Latest Developments
Table 119. Else Kooi Laboratory Details, Company Type, Human Organs-on-Chips Area Served and Its Competitors
Table 120. Else Kooi Laboratory Human Organs-on-Chips Product Offered
Table 121. Else Kooi Laboratory Human Organs-on-Chips Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 122. Else Kooi Laboratory Main Business
Table 123. Else Kooi Laboratory Latest Developments
Table 124. Altis Biosystems Details, Company Type, Human Organs-on-Chips Area Served and Its Competitors
Table 125. Altis Biosystems Human Organs-on-Chips Product Offered
Table 126. Altis Biosystems Human Organs-on-Chips Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 127. Altis Biosystems Main Business
Table 128. Altis Biosystems Latest Developments
Table 129. Bi/ond Details, Company Type, Human Organs-on-Chips Area Served and Its Competitors
Table 130. Bi/ond Human Organs-on-Chips Product Offered
Table 131. Bi/ond Human Organs-on-Chips Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 132. Bi/ond Main Business
Table 133. Bi/ond Latest Developments
Table 134. Netri Details, Company Type, Human Organs-on-Chips Area Served and Its Competitors
Table 135. Netri Human Organs-on-Chips Product Offered
Table 136. Netri Human Organs-on-Chips Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 137. Netri Main Business
Table 138. Netri Latest Developments
Table 139. Xona Microfluidics Details, Company Type, Human Organs-on-Chips Area Served and Its Competitors
Table 140. Xona Microfluidics Human Organs-on-Chips Product Offered
Table 141. Xona Microfluidics Human Organs-on-Chips Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 142. Xona Microfluidics Main Business
Table 143. Xona Microfluidics Latest Developments
Table 144. SynVivo Details, Company Type, Human Organs-on-Chips Area Served and Its Competitors
Table 145. SynVivo Human Organs-on-Chips Product Offered
Table 146. SynVivo Human Organs-on-Chips Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 147. SynVivo Main Business
Table 148. SynVivo Latest Developments
Table 149. Beijing Daxiang Biotech Details, Company Type, Human Organs-on-Chips Area Served and Its Competitors
Table 150. Beijing Daxiang Biotech Human Organs-on-Chips Product Offered
Table 151. Beijing Daxiang Biotech Human Organs-on-Chips Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 152. Beijing Daxiang Biotech Main Business
Table 153. Beijing Daxiang Biotech Latest Developments
Table 154. AVATARGET Details, Company Type, Human Organs-on-Chips Area Served and Its Competitors
Table 155. AVATARGET Human Organs-on-Chips Product Offered
Table 156. AVATARGET Human Organs-on-Chips Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 157. AVATARGET Main Business
Table 158. AVATARGET Latest Developments
Table 159. Suzhou Jiyan Biopharmaceutical Details, Company Type, Human Organs-on-Chips Area Served and Its Competitors
Table 160. Suzhou Jiyan Biopharmaceutical Human Organs-on-Chips Product Offered
Table 161. Suzhou Jiyan Biopharmaceutical Human Organs-on-Chips Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 162. Suzhou Jiyan Biopharmaceutical Main Business
Table 163. Suzhou Jiyan Biopharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Human Organs-on-Chips Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Human Organs-on-Chips Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Human Organs-on-Chips Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Human Organs-on-Chips Sales Market Share by Country/Region (2025)
Figure 8. Human Organs-on-Chips Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Human Organs-on-Chips Market Size Market Share by Type in 2025
Figure 10. Global Human Organs-on-Chips Market Size Market Share by Technology in 2025
Figure 11. Global Human Organs-on-Chips Market Size Market Share by Integration Level in 2025
Figure 12. Human Organs-on-Chips in Pharmaceutical & Biotechnology Companies
Figure 13. Global Human Organs-on-Chips Market: Pharmaceutical & Biotechnology Companies (2021-2026) & ($ millions)
Figure 14. Human Organs-on-Chips in Academic & Research Institutes
Figure 15. Global Human Organs-on-Chips Market: Academic & Research Institutes (2021-2026) & ($ millions)
Figure 16. Human Organs-on-Chips in Cosmetics Industry
Figure 17. Global Human Organs-on-Chips Market: Cosmetics Industry (2021-2026) & ($ millions)
Figure 18. Human Organs-on-Chips in Others
Figure 19. Global Human Organs-on-Chips Market: Others (2021-2026) & ($ millions)
Figure 20. Global Human Organs-on-Chips Market Size Market Share by End User in 2025
Figure 21. Global Human Organs-on-Chips Revenue Market Share by Player in 2025
Figure 22. Global Human Organs-on-Chips Market Size Market Share by Region (2021-2026)
Figure 23. Americas Human Organs-on-Chips Market Size 2021-2026 ($ millions)
Figure 24. APAC Human Organs-on-Chips Market Size 2021-2026 ($ millions)
Figure 25. Europe Human Organs-on-Chips Market Size 2021-2026 ($ millions)
Figure 26. Middle East & Africa Human Organs-on-Chips Market Size 2021-2026 ($ millions)
Figure 27. Americas Human Organs-on-Chips Value Market Share by Country in 2025
Figure 28. United States Human Organs-on-Chips Market Size Growth 2021-2026 ($ millions)
Figure 29. Canada Human Organs-on-Chips Market Size Growth 2021-2026 ($ millions)
Figure 30. Mexico Human Organs-on-Chips Market Size Growth 2021-2026 ($ millions)
Figure 31. Brazil Human Organs-on-Chips Market Size Growth 2021-2026 ($ millions)
Figure 32. APAC Human Organs-on-Chips Market Size Market Share by Region in 2025
Figure 33. APAC Human Organs-on-Chips Market Size Market Share by Type (2021-2026)
Figure 34. APAC Human Organs-on-Chips Market Size Market Share by End User (2021-2026)
Figure 35. China Human Organs-on-Chips Market Size Growth 2021-2026 ($ millions)
Figure 36. Japan Human Organs-on-Chips Market Size Growth 2021-2026 ($ millions)
Figure 37. South Korea Human Organs-on-Chips Market Size Growth 2021-2026 ($ millions)
Figure 38. Southeast Asia Human Organs-on-Chips Market Size Growth 2021-2026 ($ millions)
Figure 39. India Human Organs-on-Chips Market Size Growth 2021-2026 ($ millions)
Figure 40. Australia Human Organs-on-Chips Market Size Growth 2021-2026 ($ millions)
Figure 41. Europe Human Organs-on-Chips Market Size Market Share by Country in 2025
Figure 42. Europe Human Organs-on-Chips Market Size Market Share by Type (2021-2026)
Figure 43. Europe Human Organs-on-Chips Market Size Market Share by End User (2021-2026)
Figure 44. Germany Human Organs-on-Chips Market Size Growth 2021-2026 ($ millions)
Figure 45. France Human Organs-on-Chips Market Size Growth 2021-2026 ($ millions)
Figure 46. UK Human Organs-on-Chips Market Size Growth 2021-2026 ($ millions)
Figure 47. Italy Human Organs-on-Chips Market Size Growth 2021-2026 ($ millions)
Figure 48. Russia Human Organs-on-Chips Market Size Growth 2021-2026 ($ millions)
Figure 49. Middle East & Africa Human Organs-on-Chips Market Size Market Share by Region (2021-2026)
Figure 50. Middle East & Africa Human Organs-on-Chips Market Size Market Share by Type (2021-2026)
Figure 51. Middle East & Africa Human Organs-on-Chips Market Size Market Share by End User (2021-2026)
Figure 52. Egypt Human Organs-on-Chips Market Size Growth 2021-2026 ($ millions)
Figure 53. South Africa Human Organs-on-Chips Market Size Growth 2021-2026 ($ millions)
Figure 54. Israel Human Organs-on-Chips Market Size Growth 2021-2026 ($ millions)
Figure 55. Turkey Human Organs-on-Chips Market Size Growth 2021-2026 ($ millions)
Figure 56. GCC Countries Human Organs-on-Chips Market Size Growth 2021-2026 ($ millions)
Figure 57. Americas Human Organs-on-Chips Market Size 2027-2032 ($ millions)
Figure 58. APAC Human Organs-on-Chips Market Size 2027-2032 ($ millions)
Figure 59. Europe Human Organs-on-Chips Market Size 2027-2032 ($ millions)
Figure 60. Middle East & Africa Human Organs-on-Chips Market Size 2027-2032 ($ millions)
Figure 61. United States Human Organs-on-Chips Market Size 2027-2032 ($ millions)
Figure 62. Canada Human Organs-on-Chips Market Size 2027-2032 ($ millions)
Figure 63. Mexico Human Organs-on-Chips Market Size 2027-2032 ($ millions)
Figure 64. Brazil Human Organs-on-Chips Market Size 2027-2032 ($ millions)
Figure 65. China Human Organs-on-Chips Market Size 2027-2032 ($ millions)
Figure 66. Japan Human Organs-on-Chips Market Size 2027-2032 ($ millions)
Figure 67. Korea Human Organs-on-Chips Market Size 2027-2032 ($ millions)
Figure 68. Southeast Asia Human Organs-on-Chips Market Size 2027-2032 ($ millions)
Figure 69. India Human Organs-on-Chips Market Size 2027-2032 ($ millions)
Figure 70. Australia Human Organs-on-Chips Market Size 2027-2032 ($ millions)
Figure 71. Germany Human Organs-on-Chips Market Size 2027-2032 ($ millions)
Figure 72. France Human Organs-on-Chips Market Size 2027-2032 ($ millions)
Figure 73. UK Human Organs-on-Chips Market Size 2027-2032 ($ millions)
Figure 74. Italy Human Organs-on-Chips Market Size 2027-2032 ($ millions)
Figure 75. Russia Human Organs-on-Chips Market Size 2027-2032 ($ millions)
Figure 76. Egypt Human Organs-on-Chips Market Size 2027-2032 ($ millions)
Figure 77. South Africa Human Organs-on-Chips Market Size 2027-2032 ($ millions)
Figure 78. Israel Human Organs-on-Chips Market Size 2027-2032 ($ millions)
Figure 79. Turkey Human Organs-on-Chips Market Size 2027-2032 ($ millions)
Figure 80. Global Human Organs-on-Chips Market Size Market Share Forecast by Type (2027-2032)
Figure 81. Global Human Organs-on-Chips Market Size Market Share Forecast by End User (2027-2032)
Figure 82. GCC Countries Human Organs-on-Chips Market Size 2027-2032 ($ millions)
Figure 1. Human Organs-on-Chips Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Human Organs-on-Chips Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Human Organs-on-Chips Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Human Organs-on-Chips Sales Market Share by Country/Region (2025)
Figure 8. Human Organs-on-Chips Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Human Organs-on-Chips Market Size Market Share by Type in 2025
Figure 10. Global Human Organs-on-Chips Market Size Market Share by Technology in 2025
Figure 11. Global Human Organs-on-Chips Market Size Market Share by Integration Level in 2025
Figure 12. Human Organs-on-Chips in Pharmaceutical & Biotechnology Companies
Figure 13. Global Human Organs-on-Chips Market: Pharmaceutical & Biotechnology Companies (2021-2026) & ($ millions)
Figure 14. Human Organs-on-Chips in Academic & Research Institutes
Figure 15. Global Human Organs-on-Chips Market: Academic & Research Institutes (2021-2026) & ($ millions)
Figure 16. Human Organs-on-Chips in Cosmetics Industry
Figure 17. Global Human Organs-on-Chips Market: Cosmetics Industry (2021-2026) & ($ millions)
Figure 18. Human Organs-on-Chips in Others
Figure 19. Global Human Organs-on-Chips Market: Others (2021-2026) & ($ millions)
Figure 20. Global Human Organs-on-Chips Market Size Market Share by End User in 2025
Figure 21. Global Human Organs-on-Chips Revenue Market Share by Player in 2025
Figure 22. Global Human Organs-on-Chips Market Size Market Share by Region (2021-2026)
Figure 23. Americas Human Organs-on-Chips Market Size 2021-2026 ($ millions)
Figure 24. APAC Human Organs-on-Chips Market Size 2021-2026 ($ millions)
Figure 25. Europe Human Organs-on-Chips Market Size 2021-2026 ($ millions)
Figure 26. Middle East & Africa Human Organs-on-Chips Market Size 2021-2026 ($ millions)
Figure 27. Americas Human Organs-on-Chips Value Market Share by Country in 2025
Figure 28. United States Human Organs-on-Chips Market Size Growth 2021-2026 ($ millions)
Figure 29. Canada Human Organs-on-Chips Market Size Growth 2021-2026 ($ millions)
Figure 30. Mexico Human Organs-on-Chips Market Size Growth 2021-2026 ($ millions)
Figure 31. Brazil Human Organs-on-Chips Market Size Growth 2021-2026 ($ millions)
Figure 32. APAC Human Organs-on-Chips Market Size Market Share by Region in 2025
Figure 33. APAC Human Organs-on-Chips Market Size Market Share by Type (2021-2026)
Figure 34. APAC Human Organs-on-Chips Market Size Market Share by End User (2021-2026)
Figure 35. China Human Organs-on-Chips Market Size Growth 2021-2026 ($ millions)
Figure 36. Japan Human Organs-on-Chips Market Size Growth 2021-2026 ($ millions)
Figure 37. South Korea Human Organs-on-Chips Market Size Growth 2021-2026 ($ millions)
Figure 38. Southeast Asia Human Organs-on-Chips Market Size Growth 2021-2026 ($ millions)
Figure 39. India Human Organs-on-Chips Market Size Growth 2021-2026 ($ millions)
Figure 40. Australia Human Organs-on-Chips Market Size Growth 2021-2026 ($ millions)
Figure 41. Europe Human Organs-on-Chips Market Size Market Share by Country in 2025
Figure 42. Europe Human Organs-on-Chips Market Size Market Share by Type (2021-2026)
Figure 43. Europe Human Organs-on-Chips Market Size Market Share by End User (2021-2026)
Figure 44. Germany Human Organs-on-Chips Market Size Growth 2021-2026 ($ millions)
Figure 45. France Human Organs-on-Chips Market Size Growth 2021-2026 ($ millions)
Figure 46. UK Human Organs-on-Chips Market Size Growth 2021-2026 ($ millions)
Figure 47. Italy Human Organs-on-Chips Market Size Growth 2021-2026 ($ millions)
Figure 48. Russia Human Organs-on-Chips Market Size Growth 2021-2026 ($ millions)
Figure 49. Middle East & Africa Human Organs-on-Chips Market Size Market Share by Region (2021-2026)
Figure 50. Middle East & Africa Human Organs-on-Chips Market Size Market Share by Type (2021-2026)
Figure 51. Middle East & Africa Human Organs-on-Chips Market Size Market Share by End User (2021-2026)
Figure 52. Egypt Human Organs-on-Chips Market Size Growth 2021-2026 ($ millions)
Figure 53. South Africa Human Organs-on-Chips Market Size Growth 2021-2026 ($ millions)
Figure 54. Israel Human Organs-on-Chips Market Size Growth 2021-2026 ($ millions)
Figure 55. Turkey Human Organs-on-Chips Market Size Growth 2021-2026 ($ millions)
Figure 56. GCC Countries Human Organs-on-Chips Market Size Growth 2021-2026 ($ millions)
Figure 57. Americas Human Organs-on-Chips Market Size 2027-2032 ($ millions)
Figure 58. APAC Human Organs-on-Chips Market Size 2027-2032 ($ millions)
Figure 59. Europe Human Organs-on-Chips Market Size 2027-2032 ($ millions)
Figure 60. Middle East & Africa Human Organs-on-Chips Market Size 2027-2032 ($ millions)
Figure 61. United States Human Organs-on-Chips Market Size 2027-2032 ($ millions)
Figure 62. Canada Human Organs-on-Chips Market Size 2027-2032 ($ millions)
Figure 63. Mexico Human Organs-on-Chips Market Size 2027-2032 ($ millions)
Figure 64. Brazil Human Organs-on-Chips Market Size 2027-2032 ($ millions)
Figure 65. China Human Organs-on-Chips Market Size 2027-2032 ($ millions)
Figure 66. Japan Human Organs-on-Chips Market Size 2027-2032 ($ millions)
Figure 67. Korea Human Organs-on-Chips Market Size 2027-2032 ($ millions)
Figure 68. Southeast Asia Human Organs-on-Chips Market Size 2027-2032 ($ millions)
Figure 69. India Human Organs-on-Chips Market Size 2027-2032 ($ millions)
Figure 70. Australia Human Organs-on-Chips Market Size 2027-2032 ($ millions)
Figure 71. Germany Human Organs-on-Chips Market Size 2027-2032 ($ millions)
Figure 72. France Human Organs-on-Chips Market Size 2027-2032 ($ millions)
Figure 73. UK Human Organs-on-Chips Market Size 2027-2032 ($ millions)
Figure 74. Italy Human Organs-on-Chips Market Size 2027-2032 ($ millions)
Figure 75. Russia Human Organs-on-Chips Market Size 2027-2032 ($ millions)
Figure 76. Egypt Human Organs-on-Chips Market Size 2027-2032 ($ millions)
Figure 77. South Africa Human Organs-on-Chips Market Size 2027-2032 ($ millions)
Figure 78. Israel Human Organs-on-Chips Market Size 2027-2032 ($ millions)
Figure 79. Turkey Human Organs-on-Chips Market Size 2027-2032 ($ millions)
Figure 80. Global Human Organs-on-Chips Market Size Market Share Forecast by Type (2027-2032)
Figure 81. Global Human Organs-on-Chips Market Size Market Share Forecast by End User (2027-2032)
Figure 82. GCC Countries Human Organs-on-Chips Market Size 2027-2032 ($ millions)
More Publications
Global Capsule Endoscopy System Market Growth (Status and Outlook) 2026-2032
US$ 3,660.00
July 2026
89 pages
Global Canker Sores Drug Market Growth (Status and Outlook) 2023-2029
US$ 3,660.00
March 2023
112 pages
Global Single Coated Medical Tape Market Growth 2024-2030
US$ 3,660.00
December 2024
89 pages
Global Emergency Trauma Dressing Market Growth 2024-2030
US$ 3,660.00
June 2024
116 pages
Global Human Use Implantable Pump Market Growth 2023-2029
US$ 3,660.00
February 2023
98 pages
